Aardvark Therapeutics, Inc. (AARD)
NASDAQ:AARD
Want to see AARD full AI Analyst Report?
AARD Analyst Ratings
Hold
2 Buy
2 Hold
2 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AARD Stock 12 Month Forecast
Average Price Target
$5.00
▼(-4.40% Downside)
| Highest Price Target$7.00 | Average Price Target$5.00 | Lowest Price Target$3.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
William Blair
―
Buy
―
Reiterated
05/15/26
Bank of America Securities
$4
Sell
-23.52%
Downside
Downgraded
05/15/26
BTIG
―
Hold
―
Downgraded
05/15/26
B. Riley Securities
$8→$7
Buy
33.84%
Upside
Reiterated
05/15/26
Morgan Stanley
$7→$3
Sell
-42.64%
Downside
Downgraded
05/15/26
RBC Capital
$6
Hold
14.72%
Upside
Reiterated
05/07/26
H.C. Wainwright
―
Hold
―
Downgraded
03/02/26
Cantor Fitzgerald
$50→$45
Buy
760.42%
Upside
Reiterated
03/02/26
Stifel Nicolaus
$24→$6
Hold
14.72%
Upside
Downgraded
03/02/26
Oppenheimer
$35→$21
Buy
301.53%
Upside
Reiterated
02/27/26
Raymond James
$47
Buy
798.66%
Upside
Initiated
12/02/25
JonesTrading
$33
Buy
530.98%
Upside
Initiated
09/30/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
William Blair
―
Buy
―
Reiterated
05/15/26
Bank of America Securities
$4
Sell
-23.52%
Downside
Downgraded
05/15/26
BTIG
―
Hold
―
Downgraded
05/15/26
B. Riley Securities
$8→$7
Buy
33.84%
Upside
Reiterated
05/15/26
Morgan Stanley
$7→$3
Sell
-42.64%
Downside
Downgraded
05/15/26
RBC Capital
$6
Hold
14.72%
Upside
Reiterated
05/07/26
H.C. Wainwright
―
Hold
―
Downgraded
03/02/26
Cantor Fitzgerald
$50→$45
Buy
760.42%
Upside
Reiterated
03/02/26
Stifel Nicolaus
$24→$6
Hold
14.72%
Upside
Downgraded
03/02/26
Oppenheimer
$35→$21
Buy
301.53%
Upside
Reiterated
02/27/26
Raymond James
$47
Buy
798.66%
Upside
Initiated
12/02/25
JonesTrading
$33
Buy
530.98%
Upside
Initiated
09/30/25
Best Analysts Covering Aardvark Therapeutics, Inc.
3 Months
Success Rate
4/6 ratings generated profit
Average Return
+17.65%
Copying Michael Ulz's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +17.65% per trade.
1 Year
Success Rate
1/6 ratings generated profit
Average Return
-35.20%
Copying Michael Ulz's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -35.20% per trade.
2 Years
Success Rate
1/6 ratings generated profit
Average Return
-35.20%
Copying Michael Ulz's trades and holding each position for 2 Years would result in 16.67% of your transactions generating a profit, with an average return of -35.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
AARD Analyst Recommendation Trends
Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
11
9
7
6
2
Buy
1
2
2
4
2
Hold
0
6
6
8
2
Sell
0
0
0
2
2
Strong Sell
0
0
0
0
0
total
12
17
15
20
8
Each month's total comprises the sum of three months' worth of ratings.
AARD Financial Forecast
AARD Stock Forecast FAQ
What is AARD’s average 12-month price target, according to analysts?
Based on analyst ratings, Aardvark Therapeutics, Inc.’s 12-month average price target is 5.00.
What is AARD’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for AARD, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AARD a Buy, Sell or Hold?
Aardvark Therapeutics, Inc. has a consensus rating of Hold which is based on 2 buy ratings, 2 hold ratings and 2 sell ratings.
What is Aardvark Therapeutics, Inc.’s price target?
The average price target for Aardvark Therapeutics, Inc. is 5.00. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $7.00 ,the lowest forecast is $3.00. The average price target represents -4.40% Decrease from the current price of $5.23.
The highest analyst price target is $7.00 ,the lowest forecast is $3.00. The average price target represents -4.40% Decrease from the current price of $5.23.
What do analysts say about Aardvark Therapeutics, Inc.?
Aardvark Therapeutics, Inc.’s analyst rating consensus is a Hold. This is based on the ratings of 6 Wall Streets Analysts.
How can I buy shares of AARD?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.